An Encouraging Start to 2026
After a year when mention of the federal government often heralded bad news for research, I’m pleased to highlight positive news from our partners in the UC Office of Federal Government Relations.
With the passage of the FY 2026 appropriations package on February 3, Congress signaled its support for science by keeping funding levels at, or just below, FY 2025 levels despite the cuts proposed by the administration in 2025.
The appropriations bills included provisions that prevent any changes to the F&A rate within this cycle for most agencies that fund university research, including NIH, NSF, DOD, DOE, NASA, NOAA, and NIST. While stable for now, we expect discussions to continue for future enhancements to indirect cost recovery, including the FAIR Model.
The bill includes increased funding for Minority-Serving Institutions (MSIs) – including Hispanic-Serving Institutions, a designation for which UC Davis became eligible in 2025 – despite previous threats to eliminate these grants.
A provision limits NIH from fully obligating funds to out-year commitments (rather than NIH’s current practice of obligating most awards one year at a time), which would have drastically reduced the number of awards made in any single year. Rather, the current provision directs the NIH to fund as many new awards as possible based on meritorious applications.
We are very grateful for the support from our representatives and senators and the bipartisan efforts of the leadership of the House and Senate, who recognized the importance of robust funding for research. Your advocacy over the last year has made a difference.
While the overall outcome is encouraging, we must remain vigilant in our efforts to pursue opportunities and promote the world-changing contributions UC Davis delivers through our research and innovation. Your engagement and resilience over this last year have been a powerful testament to our shared passion for creating a brighter future for all.
For ongoing updates on federal actions related to research, visit our tracking page.
|